Back
United States Cellular Vs. Spyre Therapeutics Industry Stock Comparison
Buy
74
USM
United States Cellular
Last Price:
59.01
Seasonality Move:
3.11%
Buy
80
SYRE
Spyre Therapeutics
Last Price:
34.13
Seasonality Move:
2.56%
Buy
74
United States Cellular (USM)
is a Buy
Is United States Cellular a Buy, Sell or Hold?
- The current United States Cellular [USM] share price is $58.89. The Score for USM is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- USM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $34.15. The Score for SYRE is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
USM Stock Price Chart
What is United States Cellular's stock price today?
-
The United States Cellular share price today is $58.89
The current trend is moderately bullish and USM is experiencing selling pressure, which indicates risk of future bearish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $34.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
USM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.23 | Buy |
| Relative Strength Index (14 RSI): | 55.66 | Buy |
| Chaikin Money Flow: | -151487 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.65 - 58.67) | Buy |
| Bollinger Bands (100): | (52.76 - 57.4) | Buy |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.18 | Buy |
| Relative Strength Index (14 RSI): | 69.23 | Buy |
| Chaikin Money Flow: | 370539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.56 - 31.32) | Buy |
| Bollinger Bands (100): | (25.35 - 31.93) | Buy |
USM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.55 | Buy |
| 20-day SMA: | 56.85 | Buy |
| 50-day SMA: | 55.6 | Buy |
| 200-day SMA: | 46.97 | Buy |
| 8-day EMA: | 58.97 | Sell |
| 20-day EMA: | 57.46 | Buy |
| 50-day EMA: | 55.88 | Buy |
| 200-day EMA: | 48.66 | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.22 | Buy |
| 20-day SMA: | 29.4 | Buy |
| 50-day SMA: | 28.35 | Buy |
| 200-day SMA: | 30.28 | Buy |
| 8-day EMA: | 31.69 | Buy |
| 20-day EMA: | 30.14 | Buy |
| 50-day EMA: | 29.15 | Buy |
| 200-day EMA: | 27.73 | Buy |
United States Cellular Earnings Growth & USM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.18 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.01 per share, and a decrease next year of $0.09 per share.
United States Cellular Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||